{"id":11791,"date":"2023-08-09T06:00:00","date_gmt":"2023-08-09T00:30:00","guid":{"rendered":"https:\/\/cbirt.net\/staging\/?p=11791"},"modified":"2023-11-24T00:42:28","modified_gmt":"2023-11-23T19:12:28","slug":"exploring-deep-learning-methods-for-binding-affinity-prediction-across-proteins-and-ligands","status":"publish","type":"post","link":"https:\/\/cbirt.net\/staging\/exploring-deep-learning-methods-for-binding-affinity-prediction-across-proteins-and-ligands\/","title":{"rendered":"Exploring Deep Learning Methods for Binding Affinity Prediction Across Proteins and Ligands"},"content":{"rendered":"\n

To filter promising drug candidates early in the drug discovery process, it is imperative to accurately predict how well a protein and a potential drug molecule (ligand) will bind together. Deep learning methods are increasingly being incorporated into drug discovery, but they struggle to be as versatile as conventional methods due to their suboptimal abilities in extrapolating previously learned information onto new scenarios. Hence, researchers from the University of Edinburgh have attempted to understand what these models are learning from protein and ligand information. They used a deep learning model that relies on sequential and structural information on kinase datasets. Their findings indicate that the deep learning model is much more influenced by ligand information than by protein information.  <\/em><\/p>\n\n\n\n

The Use of AI in Drug Discovery<\/h2>\n\n\n\n

Predicting the binding affinity between a protein and a ligand helps in the quicker identification of appropriate drug candidates without the aid of time-consuming experiments. Many methods have been developed for predicting the binding strength between proteins and ligands<\/a>, but all of them are accompanied by limitations, especially when it comes to a large number of compounds. Methods utilizing computer simulations are often inaccurate, and other accurate methods take up a huge amount of computational power. Recently, scientists have included machine learning methods in drug discovery to enhance binding strength prediction.<\/p>\n\n\n\n

But even machine learning models struggle with a drawback. They fail to generalize the information they learned during their training and perform suboptimally when presented with new scenarios. To understand how exactly these models work and what improvements could be incorporated into them, researchers used a deep learning model on kinase datasets that takes protein and ligand information as input and analyze the factors on which the results depend.<\/p>\n\n\n\n

For proteins, they provide sequential information (like the letters of a word) and also patterns of interactions between parts of the protein (like analyzing a map). For ligands, they use the information in their structures. They also use information on how proteins and drugs are combined. They run a lot of experiments to analyze the relationship between the information given to the model and the accuracy with which it predicts the binding affinity.<\/p>\n\n\n\n

Methods Employed for Predicting Binding Affinity with Deep Learning<\/h2>\n\n\n\n

Two types of kinase datasets were utilized in this study, Davis and KIBA. Davis consists of measurements of the strengths of the interactions between kinases and inhibitors, and KIBA combines various sources about how well various compounds interact with specific proteins. The datasets were divided into parts for training and testing the models.<\/p>\n\n\n\n

By employing various encoding schemes, the researchers sought to predict these interactions. They adapted algorithms to encode proteins as sequences of numbers and graphs, and ligands as graphs that represent their chemical makeup. For encoding proteins, multiple methods were employed. <\/p>\n\n\n\n

One of the methods used a language model trained on a lot of protein sequences<\/a>. Another one utilized a database to track how proteins interact with other molecules. Then, these encodings were fed as inputs into neural networks. In the case of ligands, their chemical structures<\/a> were converted into graphs, and the graphs were transformed into numerical encodings.<\/p>\n\n\n\n

A complex deep learning model was built that combined these encodings to predict the strength of the interactions between the proteins and ligands. The researchers also tested how the predictions changed when small changes were made in the graphs representing the proteins and the ligands.<\/p>\n\n\n\n

At last, statistical measures like Wilcoxon’s signed rank test were employed to evaluate how well the predictions matched the actual data.<\/p>\n\n\n\n

An Overview of the Performance of the Model<\/h2>\n\n\n\n

Comparing PCM Prediction Methods<\/h3>\n\n\n\n